Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT) (TARGIT)
Implementation of the Target Intraoperative Therapy Registry at Bethesda North TriHealth Hospital (TARGIT)
Sponsor: Bethesda North Hospital Foundation
Terminated
Study site will join the TARGIT-US trial in lieu of this trial
Other Breast Tumor trials with similar outcome
This observational or N/A phase trial investigates Breast Tumor and Early Stage Breast Cancer and is currently terminated or withdrawn. Bethesda North Hospital Foundation leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Sep 2018 — Jan 2021 [monthly]
Terminated
-
Jun 2018 — Sep 2018 [monthly]
Terminated
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bethesda North Hospital Foundation
- TriHealth Hatton Research Institute
- TriHealth Inc.
For direct contact, visit the study record on ClinicalTrials.gov .